SCHEMBL4959294

SCHEMBL4959294

CCCCC(=O)Nc1ccsc1C(=O)OC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.63
KMT2A Q03164 3/20 0.63
TDP1 Q9NUW8 2/20 0.63
MEN1 O00255 2/20 0.63
MAPT P10636 2/20 0.63
CASP3 P42574 2/20 0.62
SENP7 Q9BQF6 2/20 0.62
SENP6 Q9GZR1 2/20 0.62
L3MBTL1 Q9Y468 2/20 0.62
MAPK8 P45983 4/20 0.61
MAPK10 P53779 4/20 0.61
MAPK9 P45984 3/20 0.61
HTT P42858 1/20 0.60
SMN1; SMN2 Q16637 2/20 0.59
LMNA P02545 1/20 0.59
HPGD P15428 1/20 0.59
ATM Q13315 1/20 0.59
SENP8 Q96LD8 1/20 0.59
NPC1 O15118 1/20 0.58
MAPK1 P28482 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17817419 0.94 ALDH1A1 (0.60) ALDH1A1KMT2ATDP1MEN1MAPT
SCHEMBL5106577 0.91 KMT2A (0.66) ALDH1A1KMT2ATDP1MEN1MAPT
SCHEMBL4958864 0.85 ABCC1 (0.60) ALDH1A1KMT2ATDP1MEN1MAPT
SCHEMBL4787145 0.84 KMT2A (0.64) ALDH1A1KMT2ATDP1MEN1MAPT
SCHEMBL24104683 0.84 MAPK8 (0.62) ALDH1A1KMT2ATDP1MEN1MAPT
SCHEMBL5294918 0.82 MAPK8 (0.68) ALDH1A1KMT2AMEN1MAPTCASP3
SCHEMBL7933290 0.81 MAPK8 (0.66) ALDH1A1KMT2AMEN1MAPTCASP3
SCHEMBL28722481 0.81 MAPK8 (0.66) ALDH1A1KMT2AMEN1MAPTCASP3
SCHEMBL4749588 0.81 SMN1; SMN2 (0.67) ALDH1A1KMT2AMEN1MAPTCASP3
SCHEMBL16760967 0.81 MAPK8 (0.66) ALDH1A1KMT2AMEN1MAPTCASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008094909-A2 QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-08-07 WO disclosed
EP-0915093-B1 AMIDE DERIVATIVES OTSUKA PHARMA CO LTD (JP) 2002-11-27 EP disclosed
US-6166016-A Amide derivatives OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 2000-12-26 US disclosed
EP-0915093-A1 AMIDE DERIVATIVES OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1999-05-12 EP disclosed